The mega pharmaceutical firm Pfizer and the German biotech company BioNTech collaborated to codevelop COVID-19 vaccine candidate in an unprecedented manner.
As per the interim report of an early phase trial, the vaccine is touted to elicit a robust immune response in healthy adults. As part of the examination, the vaccine was administered in 45 healthy individuals in the age group of 18-55 years.
The researchers stated about the vaccine candidate BNT162b1as an RNA vaccine that induces an immune response by simulating the mRNA molecule utilised for the novel coronavirus SARS-CoV-2 to develop its infectious proteins.
Based on the research report, the vaccine candidate is designed to be delivered intramuscularly, which facilitates human cells to release protein part of the SARS-CoV-2 receptor-binding domain, where the immune system is trained to produce antibodies against it.
Researchers said that volunteers in the 10-g and 30-g groups were administered a second dose too on day 21. Although, the scientists observed mild to moderate side effects of the vaccine candidate, they claimed that the antibodies for covid-19 has developed within 21 days and hoped that it would lay a path in bringing a pioneering change in the vaccine development.
Engaging content is key to a film’s success, often overshadowing the need for star-studded casts.…
Egg freezing is emerging as a trend among movie stars. Notably, actress Mrunal Thakur has…
The production team of Power Star Pawan Kalyan’s PAN-Indian film, Hari Hara Veera Mallu, has…
Global star Ram Charan fans are excited as his new big pan india film, 'Game…
Sabari, starring Varalaxmi Sarathkumar, is gearing up for its premiere on May 3rd. The film…
Bollywood actor Ranveer Singh danced with 'Rock Star' Devi Sri Prasad for a lively item…